Tenders Are Invited For Pharmaceutical Products – Sugammadex

Pharmaceutical Products – Sugammadex. Purpose Of The Contract The Purpose Of This Contract Is To Supply Pharmacies On The Various Sites Of The Contracting Authority With Sugammadex (Atc V03ab35) In The Form Of An Injectable Solution At 100 Mg/Ml. Delivery Locations For Chirec Asbl Supplies, Sites: • Braine-Lalleud Hospital - Waterloo – Rue Wayez 35 – 1420 Braine-Lalleud • Delta Hospital – Boulevard Du Triomphe 201 – 1160 Brussels • Sainte-Anne Saint-Remi Clinic – Boulevard Jules Graindor 66 – 1070 Brussels Allotment Given Its Indivisible Nature, This Contract Is Not Divided Into Lots. Single Batch: Sugammadex Single Batch: 100 Mg/Ml Injectable Solution Options None. Variants None. Duration Of The Contract The Contract Will Be Concluded For An Initial Duration Of 2 Years, Tacitly Renewable Twice For Successive Terms Of 1 Year, Thus Bringing The Maximum Duration Of The Contract To 4 Years (2+1+1). At The Latest 2 Months Before The End Of The Current Term, The Contracting Authority May Waive The Tacit Renewal. This Waiver Must Not Be Motivated And Will Not Give Any Right To Compensation To The Successful Bidders. Orders Issued Before The Market Expiration Date Will Remain Executable. Estimated Value Of The Contract Based On The Current Purchasing Data Of The Contracting Authority, The Value Of The Contract Is Estimated At An Annual Amount Of Approximately €75,500 Excluding Vat, Or €302,000 Excluding Vat For The Total Duration Of The Contract (4 Years).